TrialMolecular medicine (Cambridge, Mass.)2024
Empagliflozin's role in early tubular protection for type 2 diabetes patients.
Chuangbiao Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it